We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
DUTASTERIDE/TAMSULOSIN VIATRIS (Helix Pharmaceuticals Pty Ltd)
Product name
DUTASTERIDE/TAMSULOSIN VIATRIS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
153 (255 working days)
Active ingredients
dutasteride, tamsulosin hydrochloride
Registration type
New generic medicine
Indication
TRADENAME is indicated for the management of moderate to severe symptomatic benign prostatic hyperplasia (BPH).